Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

Published:2015-03-23 Issue:5 Volume:61 Page:1471-1478
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Younossi Zobair M.¹²,Jiang Yushan³,Smith Nathaniel J.³,Stepanova Maria²⁴,Beckerman Rachel³

Affiliation:

1. Center for Liver Diseases, Department of Medicine; Inova Fairfax Hospital; Falls Church VA

2. Center for Outcomes Research in Liver Diseases; Washington DC

3. CBPartners; New York NY

4. Betty and Guy Beatty Center for Integrated Research; Inova Health System; Falls Church VA

Publisher

Wiley

Subject

Hepatology

Reference48 articles.

1. http://www.who.int/mediacentre/factsheets/fs164/en/ 2014

2. Hepatitis C and work impairment: a review of current literature;Manne;J Clin Gastroenterol,2014

3. Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease;Gordon;Aliment Pharmacol Ther,2013

4. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective;McAdam-Marx;J Manag Care Pharm,2011

5. Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection;Saab;Aliment Pharmacol Ther,2014

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease;Clinics in Liver Disease;2023-05

2. Severe impairment of patient‐reported outcomes in patients with chronic hepatitis C virus infection seen in real‐world practices across the world: Data from the global liver registry;Journal of Viral Hepatitis;2022-09-07

3. Patient-Reported Outcomes in Hepatitis C Infection;Hepatitis C: Care and Treatment;2021

4. The Economic Value of Improved Productivity from Treatment of Chronic Hepatitis C Virus Infection: A Retrospective Analysis of Earnings, Work Loss, and Health Insurance Data;Advances in Therapy;2020-09-14

5. Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: a nationwide register study;BMJ Open;2020-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3